‘The View’ Doesn’t Want Trump to Succeed on Drug Prices

“The View” erupted into one of its familiar anti-Trump spirals Tuesday after co-hosts Joy Behar and Sunny Hostin reacted with visible outrage to President Donald Trump lowering the price of hundreds of prescription drugs through a new federal direct-to-consumer program called TrumpRx.

Instead of focusing primarily on the lower costs for Americans struggling with medication expenses, Behar and Hostin spent much of the segment attacking Trump personally and questioning his motives.

The Trump administration recently expanded the TrumpRx platform to include more than 600 prescription medications available at significantly reduced prices. The program is aimed at helping Americans purchase medications directly while bypassing some traditional pricing markups.

But on “The View,” the announcement immediately triggered hostility.

“First of all, you lie down with dogs, you wake up with fleas,” Behar declared.

“Once Trump puts his name on prescriptions, we’re all going to die, okay?” she continued before launching into a list of Trump-branded business ventures she claimed had failed over the years.

“He put his name on the Trump Shuttle, the Trump Vodka, Trump University, the Trump Hotel, and my favorite, the casinos that all went bankrupt.”

Sunny Hostin quickly joined in.

“I completely agree,” she said, describing Trump as a “failed businessman” before bizarrely criticizing him for saying he wanted to help make Americans “wealthy” through lower costs.

“He didn’t say healthy,” Hostin argued.

“This is not a well-intentioned person,” she continued. “He is not doing this out of the goodness of his heart.”

The reaction created an unusual split at the table because some of the show’s other liberal co-hosts were unwilling to dismiss the actual impact of lower drug prices simply because Trump was involved.

Sara Haines pushed back directly.


“This helps people,” Haines said. “People who are literally suffering from illness and cannot pay for their medicine.”

Hostin responded by calling her “so naive.”

Alyssa Farah Griffin also defended the policy’s practical effects, citing her own experience.

“A medication I had to take for IVF is a tenth of the price on TrumpRx,” Griffin explained.

She acknowledged that branding the program with Trump’s name was “tacky,” but argued that the real-world savings mattered far more than political irritation.

“The average family — one third of Americans — cuts back on essential foods and utilities to be able to cover their prescription drug costs,” Griffin said.

“You’re not going to convince me that, just because Trump is involved, we should be like, ‘Screw it, don’t bring down prescription drugs.’”

The exchange highlighted an increasingly awkward dynamic for many Trump critics: how to respond when policies associated with him produce outcomes that are difficult to attack directly.

Prescription drug costs remain one of the most unpopular financial burdens facing Americans, with many families routinely forced to ration medication, delay treatment, or cut spending elsewhere simply to afford prescriptions.

That reality made the segment especially uncomfortable for critics who appeared more focused on Trump himself than on whether lower prices might actually help struggling patients.